Antiarrhythmic drugs use in elderly patients. Vaughan Williams class III and IV drugs

The effectiveness of antiarrhythmic drugs in the elderly is similar to that in younger patients. However data for «the very elderly» are lacking. Elderly patients are more vulnerable to adverse drug reactions (ADRs) because of age-related changes of pharmacokinetics, co-morbidity and drug interactions. Amioadarone is not considered as the drug of choice in elderly patients because of the high risk of serious ADRs. Other class III drugs should be prescribed to the elderly with great caution under close monitoring of the treatment. Diltiazem and verapamil should not be used in elderly patients with NYHA class III-IV heart failure and should not be combined with β-blockers.

Authors
Ushkalova E.A. 1 , Zyryanov S.K. 1 , Zatolochina K.E. 1 , Pereverzev A.P. 1 , Chukhareva N.A.2
Journal
Rational Pharmacotherapy in Cardiology
Publisher
Stolichnaya Izdatelskaya Kompaniya
Number of issue
5
Language
Russian
Pages
603-609
Status
Published
Link
External link
DOI
10.20996/1819-6446-2016-12-5-603-609
Volume
12
Year
2016
Organizations
  • 1 People's Friendship University of Russia, Miklukho-Maklaya ul. 6, Moscow, 117198, Russian Federation
  • 2 Scientific Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Academika Oparina ul. 4, Moscow, 117997, Russian Federation
Keywords
Class III and IV antiarrhythmic drugs; Elderly patients
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/4190/
Share

Other records